Filing Details
- Accession Number:
- 0001181431-13-029417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-21 16:33:58
- Reporting Period:
- 2013-05-17
- Filing Date:
- 2013-05-21
- Accepted Time:
- 2013-05-21 16:33:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
936728 | A Roy Whitfield | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-05-17 | 40,000 | $23.08 | 721,082 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Represents weighted average sale price. Actual sales prices ranged from $22.78 to $23.40.
- Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.